NPI: 1982273157 · SANFORD, FL 32771 · Pediatrics Physician · NPI assigned 06/22/2021
Authorized official BRIDGES, ROBERT controls 18+ related entities in our dataset. Read more
| Authorized Official | BRIDGES, ROBERT (EVP, OPERATIONS) |
| Parent Organization | CHILDREN'S HEALTH ALLIANCE, LLC |
| NPI Enumeration Date | 06/22/2021 |
Other providers sharing the same authorized official: BRIDGES, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 2,757 | $141K |
| 2022 | 8,639 | $463K |
| 2023 | 9,419 | $533K |
| 2024 | 5,131 | $235K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,533 | 7,039 | $514K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,836 | 1,764 | $197K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,593 | 1,460 | $159K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,457 | 1,355 | $149K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2,417 | 2,205 | $103K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 587 | 556 | $65K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 800 | 679 | $64K |
| 90461 | 1,412 | 1,226 | $43K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 291 | 283 | $26K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 95 | 70 | $11K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 612 | 571 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 123 | 120 | $10K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 65 | 62 | $6K |
| 90670 | 262 | 255 | $2K | |
| 90734 | 53 | 53 | $2K | |
| 96127 | 1,240 | 1,072 | $1K | |
| 99173 | 638 | 559 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 94 | 94 | $1K |
| 92551 | 1,102 | 951 | $1K | |
| 90686 | 757 | 741 | $964.68 | |
| 85018 | 530 | 496 | $813.14 | |
| 99177 | 352 | 304 | $787.50 | |
| 83655 | 102 | 95 | $687.13 | |
| 99188 | 42 | 39 | $595.48 | |
| 80061 | Lipid panel | 50 | 46 | $397.90 |
| 90633 | 113 | 112 | $335.15 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15 | 15 | $300.52 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 25 | 24 | $253.45 |
| 90674 | 16 | 15 | $246.00 | |
| 36416 | 961 | 882 | $195.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 234 | 192 | $121.73 |
| 96161 | 104 | 81 | $40.80 | |
| 90656 | 45 | 45 | $22.03 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 24 | 12 | $0.13 |
| 90671 | 12 | 12 | $0.00 | |
| 90700 | 12 | 12 | $0.00 | |
| 90723 | 107 | 107 | $0.00 | |
| 90647 | 117 | 116 | $0.00 | |
| 90651 | 67 | 65 | $0.00 | |
| 90680 | 51 | 51 | $0.00 |